Cargando…
Combined therapy with early initiation of infliximab following drainage of perianal fistulising Crohn’s disease: a retrospective cohort study
BACKGROUND: Recent studies have confirmed that combined surgery and anti-TNF therapy could improve outcomes in patients with perianal fistulising Crohn’s disease (PFCD). However, the optimal timing for infliximab infusion after surgical intervention is uncertain. We aimed to determine the long-term...
Autores principales: | Zhu, Ping, Sun, Jin-fang, Gu, Yun-fei, Chen, Hong-jin, Xu, Min-min, Li, You-ran, Yang, Bo-lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751033/ https://www.ncbi.nlm.nih.gov/pubmed/35012467 http://dx.doi.org/10.1186/s12876-021-02078-9 |
Ejemplares similares
-
ANALYSIS OF THE CLINICAL CHARACTERISTICS OF PERIANAL FISTULISING CROHN’S DISEASE IN A SINGLE CENTER
por: XU, Min-Min, et al.
Publicado: (2019) -
Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn’s disease
por: Gu, Bonita, et al.
Publicado: (2022) -
Novel Approaches to Ileocolic and Perianal Fistulising Crohn's Disease
por: Luglio, Gaetano, et al.
Publicado: (2018) -
Review of local injection of anti-TNF for perianal fistulising Crohn’s disease
por: Adegbola, Samuel O., et al.
Publicado: (2017) -
Developing a core outcome set for fistulising perianal Crohn’s disease
por: Sahnan, Kapil, et al.
Publicado: (2019)